Folate status and homocysteine level in Italian patients aged under 60 on oral anticoagulant therapy

Annals of Medicine

Volumn 35, Issue 2, 2003, Pages 140-144

  Cafolla, Arturo ^a,d   Dragoni, Francesco ^a   Puopolo, Maria ^b   Ruzzi, Laura ^c   Chiarotti, Flavia ^b   Silvestri, Lorena ^c   Bongarzoni, Velia ^a   Simioni, Paolo ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d NONE

Author keywords

Folate status; Homocysteine; Patients on oral anticoagulant therapy

Indexed keywords

ANTICOAGULANT AGENT; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DIET; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; GENE; GENE MUTATION; HOMOCYSTEINE BLOOD LEVEL; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; ITALY; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTICOAGULANTS; DIET; ERYTHROCYTES; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INTERNATIONAL NORMALIZED RATIO; ITALY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; THROMBOSIS;

EID: 0038441650     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890310010041     Document Type: Article

References (22)

1. Verhoef P, Stampfer MJ, Buring JE, Graziano JM, Allen RH, Stabler SP, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Am J Epidemiol 1996; 143: 845-59.
2. Durand P, Prost M, Blanche D. Folate deficiencies and cardiovascular pathologies. Clin Chem Lab Med 1998; 36: 419-29.
3. Cafolla A, Dragoni F, Girelli G, Tosti ME, Costante A, Pastorelli D, et al. Folate status in Italian blood donors: relation to gender and smoking. Haematologica 2000; 85: 694-8.
4. Morrison HI, Schauebel D, Desmeules M, Wigle DT. Serum folate and risk of fatal coronary heart disease. JAMA 1996; 275: 1893-6.
5. Kang SS, Wong PW. Genetic and non-genetic factors for moderate hyperhomocysteinemia. Atherosclerosis 1996; 119: 135-8.
6. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996; 93: 7-9.
7. den Heijer M, Koster T, Blom H, Bos G, Briet E, Reitsma P, et al. Hyperhomocysteinemia: as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759-62.
8. Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, et al. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes. Thromb Haemost 1999; 81: 506-10.
9. Meisel C, Cascorbi I, Gerloff T, Stangl V, Laule M, Muller JM, et al. Identification of six methylenetetrahydrofolate reductase (MTHFR) genotypes resulting from common polymorphism; impact on plasma homocysteine levels and development of coronary artery disease. Atherosclerosis 2001; 154: 651-8.
10. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA 1995; 274: 1526-33.
11. Sumner AE, Chin MM, Abrahm JL, Berry GT, Gracely EJ, Allen RH, et al. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surgery. Ann Intern Med 1996; 124: 469-76.
12. Murùa A, Quintana J, Galarza C, Alfie J, Kordich L. Unsuspected Hyper homocysteinemia in chronically anticoagulated patients. Blood Coagul Fibrinolysis 2001; 12: 79-80.
13. Lensing AW, Prandoni P, Prins MH, Buller HR. Deep vein thrombosis. Lancet 1999; 353: 479-85.
14. Palareti G, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, et al. Thrombotic events during oral anticoagulant treatment results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT Study Group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost 1997; 78: 1438-43.
15. Lubetsky A, Dekel-Stern E, Chefrit A, Lubin F, Halkin H. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets. Thromb Haemost 1999; 81: 396-9.
16. SINU. Società Italiana di Nutrizione Umana. Livelli di assunzione raccomandati di energia e nutrienti per la popolazione italiana. LARN, Revisione 1996: 103-4.
17. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-3.
18. BMDP. Statistical Software Manual. Berkeley, University of California Press 1990.
19. Cafolla A, Dragoni F, Girelli G, Tosti ME, Monarca B, Kendall R, et al. Red cell folate in elderly patients with myelodysplastic sindrome. Eur J Haematol 1998; 61: 160-3.
20. Reisenauer AM, Krumdieck CI, Halsted CH. Folate conjugase: two separate activities in human jejunum. Science 1977; 198: 196.
21. Durand P, Prost M, Blache D. Pro-thrombotic effects of a folic acid deficient in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 1996; 121: 231-43.
22. Title LM, Cummings PM, Giddens K, Genest JJ Jr., Nassar BA. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol 2000; 36: 758-65.